Frequency Therapeutics has registered an initial public offering of common stock worth $100 million.
Woburn, Mass.-based Frequency Therapeutics did not disclose the number of shares it seeks to sell or the price range of the offered units. The company applied to the Securities and Exchange Commission have its common stock listed on The Nasdaq Global Market under the symbol “FREQ.”
J.P. Morgan, Goldman Sachs, Cowen and Mizuho Securities are expected to deliver the shares for the offering, according to the SEC filing.
Get the full story at our sister site, Drug Delivery Business News.